Financial comparisons Northwest Biotherapeutics, Inc. Börse Stuttgart
Stocks
NBYB
US66737P6007
Biotechnology & Medical Research
|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.1800 EUR | 0.00% |
|
+36.36% | -12.62% |
Main competitors
| Revenues (N-1) | Net Margin (N-1) | EBIT Margin (N-1) | ROE (N-1) | ROA (N-1) | Leverage (N-1) | ||
|---|---|---|---|---|---|---|---|
| 6.5B | 42.13% | 52.64% | 28.56% | 20.88% | -0.99x | ||
| 4.25B | 30.41% | 24.81% | 20.15% | 17.36% | -3.18x | ||
| 606M | -210.54% | -205.59% | -249.28% | - | 0.72x | ||
| 3.12B | 22.53% | 31.44% | 11.9% | 8.13% | -1.19x | ||
| 3.37B | -39.59% | -48.95% | -5.88% | -5.1% | 6.99x | ||
| 3.69B | 25.89% | 28.63% | 17.53% | 9.99% | -1.51x | ||
| 498M | 32.27% | 31.52% | 16.97% | 14.74% | -3.83x | ||
| 294M | -18.56% | -24.05% | -9.34% | -9.05% | 8.22x | ||
| 2.32B | 33.73% | 37.59% | 35.53% | 27.02% | -1.18x | ||
| 829M | -0.2% | 11.86% | -0.5% | - | -6.61x | ||
| 437M | -36.42% | -29.57% | -7.45% | -7.74% | 6.67x | ||
| 958M | -30.08% | -31.31% | -42.49% | - | 2.15x | ||
| 88.04M | -891.6% | -695.44% | - | -55.55% | 0.05x | ||
| 463M | 21.89% | 22.29% | 25.37% | 11.13% | 2.45x | ||
| 7.7M | -6,046.22% | -6,714.77% | -40.17% | - | 2x | ||
| 113M | -310.18% | -226% | - | - | - | ||
| Average | 1.72B | -460.91% | -483.43% | -14.22% | 2.89% | 0.72x | |
| Weighted average by Cap. | 2.97B | -197.57% | -204.58% | -11.93% | 9.52% | -0.01x |
- Stock Market
- Stocks
- NWBO Stock
- NBYB Stock
- Sector Northwest Biotherapeutics, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
















